8-K
Current Report
Cocrystal Pharma, Inc. Filed Acc 0001521536-13-000874
Agreement ended
- Item 1.02 Termination of a material definitive agreement
From the SEC's structured data for this filing
Loading q1101294_8k-biozone.htm…